This page is part of the FHIR Specification (v4.4.0: R5 Preview #2). The current version which supercedes this version is 5.0.0. For a full list of available versions, see the Directory of published versions . Page versions: R5 R4B
Biomedical Research and Regulation Work Group | Maturity Level: 1 | Trial Use | Security Category: Anonymous | Compartments: Not linked to any defined compartments |
A pharmaceutical product described in terms of its composition and dose form.
Qualitative and quantitative composition of a Medicinal Product in the dose form approved for administration in line with the regulated product information
Note that in many instances, the pharmaceutical product is equal to the manufactured item. However, there are instances where the manufactured item must undergo a transformation before being administered to the patient (as the pharmaceutical product) and the two are not equal.
This resource is referenced by MedicinalProductDefinition.
This resource does not implement any patterns.
Structure
Name | Flags | Card. | Type | Description & Constraints |
---|---|---|---|---|
AdministrableProductDefinition | ΣTU | DomainResource | A pharmaceutical product described in terms of its composition and dose form Elements defined in Ancestors: id, meta, implicitRules, language, text, contained, extension, modifierExtension | |
identifier | Σ | 0..* | Identifier | An identifier for the pharmaceutical medicinal product |
subject | Σ | 0..* | Reference(MedicinalProductDefinition) | The product that this is a pharmaceutical product of |
administrableDoseForm | Σ | 1..1 | CodeableConcept | The administrable dose form, after necessary reconstitution |
unitOfPresentation | Σ | 0..1 | CodeableConcept | Todo |
producedFrom | Σ | 0..* | Reference(ManufacturedItemDefinition) | The manufactured item(s) that this administrable product is produced from. Either a single item, or several that are mixed before administration (e.g. a power item and a solution item). Note that these are not raw ingredients |
ingredient | Σ | 0..* | Reference(Ingredient) | The ingredients of this administrable pharmaceutical product |
device | Σ | 0..* | Reference(DeviceDefinition) | Accompanying device |
property | Σ | 0..* | BackboneElement | Characteristics e.g. a products onset of action |
type | Σ | 1..1 | CodeableConcept | A code expressing the type of characteristic |
value[x] | Σ | 0..1 | A value for the characteristic | |
valueCodeableConcept | CodeableConcept | |||
valueQuantity | Quantity | |||
valueDate | date | |||
valueBoolean | boolean | |||
valueAttachment | Attachment | |||
status | Σ | 0..1 | CodeableConcept | The status of characteristic e.g. assigned or pending |
routeOfAdministration | Σ | 1..* | BackboneElement | The path by which the pharmaceutical product is taken into or makes contact with the body |
code | Σ | 1..1 | CodeableConcept | Coded expression for the route |
firstDose | Σ | 0..1 | Quantity | The first dose (dose quantity) administered in humans can be specified, for a product under investigation, using a numerical value and its unit of measurement |
maxSingleDose | Σ | 0..1 | Quantity | The maximum single dose that can be administered as per the protocol of a clinical trial can be specified using a numerical value and its unit of measurement |
maxDosePerDay | Σ | 0..1 | Quantity | The maximum dose per day (maximum dose quantity to be administered in any one 24-h period) that can be administered as per the protocol referenced in the clinical trial authorisation |
maxDosePerTreatmentPeriod | Σ | 0..1 | Ratio | The maximum dose per treatment period that can be administered as per the protocol referenced in the clinical trial authorisation |
maxTreatmentPeriod | Σ | 0..1 | Duration | The maximum treatment period during which an Investigational Medicinal Product can be administered as per the protocol referenced in the clinical trial authorisation |
targetSpecies | Σ | 0..* | BackboneElement | A species for which this route applies |
code | Σ | 1..1 | CodeableConcept | Coded expression for the species |
withdrawalPeriod | Σ | 0..* | BackboneElement | A species specific time during which consumption of animal product is not appropriate |
tissue | Σ | 1..1 | CodeableConcept | Coded expression for the type of tissue for which the withdrawal period applues, e.g. meat, milk |
value | Σ | 1..1 | Quantity | A value for the time |
supportingInformation | Σ | 0..1 | string | Extra information about the withdrawal period |
Documentation for this format |
UML Diagram (Legend)
XML Template
<AdministrableProductDefinition xmlns="http://hl7.org/fhir"> <!-- from Resource: id, meta, implicitRules, and language --> <!-- from DomainResource: text, contained, extension, and modifierExtension --> <identifier><!-- 0..* Identifier An identifier for the pharmaceutical medicinal product --></identifier> <subject><!-- 0..* Reference(MedicinalProductDefinition) The product that this is a pharmaceutical product of --></subject> <administrableDoseForm><!-- 1..1 CodeableConcept The administrable dose form, after necessary reconstitution --></administrableDoseForm> <unitOfPresentation><!-- 0..1 CodeableConcept Todo --></unitOfPresentation> <producedFrom><!-- 0..* Reference(ManufacturedItemDefinition) The manufactured item(s) that this administrable product is produced from. Either a single item, or several that are mixed before administration (e.g. a power item and a solution item). Note that these are not raw ingredients --></producedFrom> <ingredient><!-- 0..* Reference(Ingredient) The ingredients of this administrable pharmaceutical product --></ingredient> <device><!-- 0..* Reference(DeviceDefinition) Accompanying device --></device> <property> <!-- 0..* Characteristics e.g. a products onset of action --> <type><!-- 1..1 CodeableConcept A code expressing the type of characteristic --></type> <value[x]><!-- 0..1 CodeableConcept|Quantity|date|boolean|Attachment A value for the characteristic --></value[x]> <status><!-- 0..1 CodeableConcept The status of characteristic e.g. assigned or pending --></status> </property> <routeOfAdministration> <!-- 1..* The path by which the pharmaceutical product is taken into or makes contact with the body --> <code><!-- 1..1 CodeableConcept Coded expression for the route --></code> <firstDose><!-- 0..1 Quantity The first dose (dose quantity) administered in humans can be specified, for a product under investigation, using a numerical value and its unit of measurement --></firstDose> <maxSingleDose><!-- 0..1 Quantity The maximum single dose that can be administered as per the protocol of a clinical trial can be specified using a numerical value and its unit of measurement --></maxSingleDose> <maxDosePerDay><!-- 0..1 Quantity The maximum dose per day (maximum dose quantity to be administered in any one 24-h period) that can be administered as per the protocol referenced in the clinical trial authorisation --></maxDosePerDay> <maxDosePerTreatmentPeriod><!-- 0..1 Ratio The maximum dose per treatment period that can be administered as per the protocol referenced in the clinical trial authorisation --></maxDosePerTreatmentPeriod> <maxTreatmentPeriod><!-- 0..1 Duration The maximum treatment period during which an Investigational Medicinal Product can be administered as per the protocol referenced in the clinical trial authorisation --></maxTreatmentPeriod> <targetSpecies> <!-- 0..* A species for which this route applies --> <code><!-- 1..1 CodeableConcept Coded expression for the species --></code> <withdrawalPeriod> <!-- 0..* A species specific time during which consumption of animal product is not appropriate --> <tissue><!-- 1..1 CodeableConcept Coded expression for the type of tissue for which the withdrawal period applues, e.g. meat, milk --></tissue> <value><!-- 1..1 Quantity A value for the time --></value> <supportingInformation value="[string]"/><!-- 0..1 Extra information about the withdrawal period --> </withdrawalPeriod> </targetSpecies> </routeOfAdministration> </AdministrableProductDefinition>
JSON Template
{ "resourceType" : "AdministrableProductDefinition", // from Resource: id, meta, implicitRules, and language // from DomainResource: text, contained, extension, and modifierExtension "identifier" : [{ Identifier }], // An identifier for the pharmaceutical medicinal product "subject" : [{ Reference(MedicinalProductDefinition) }], // The product that this is a pharmaceutical product of "administrableDoseForm" : { CodeableConcept }, // R! The administrable dose form, after necessary reconstitution "unitOfPresentation" : { CodeableConcept }, // Todo "producedFrom" : [{ Reference(ManufacturedItemDefinition) }], // The manufactured item(s) that this administrable product is produced from. Either a single item, or several that are mixed before administration (e.g. a power item and a solution item). Note that these are not raw ingredients "ingredient" : [{ Reference(Ingredient) }], // The ingredients of this administrable pharmaceutical product "device" : [{ Reference(DeviceDefinition) }], // Accompanying device "property" : [{ // Characteristics e.g. a products onset of action "type" : { CodeableConcept }, // R! A code expressing the type of characteristic // value[x]: A value for the characteristic. One of these 5: "valueCodeableConcept" : { CodeableConcept }, "valueQuantity" : { Quantity }, "valueDate" : "<date>", "valueBoolean" : <boolean>, "valueAttachment" : { Attachment }, "status" : { CodeableConcept } // The status of characteristic e.g. assigned or pending }], "routeOfAdministration" : [{ // R! The path by which the pharmaceutical product is taken into or makes contact with the body "code" : { CodeableConcept }, // R! Coded expression for the route "firstDose" : { Quantity }, // The first dose (dose quantity) administered in humans can be specified, for a product under investigation, using a numerical value and its unit of measurement "maxSingleDose" : { Quantity }, // The maximum single dose that can be administered as per the protocol of a clinical trial can be specified using a numerical value and its unit of measurement "maxDosePerDay" : { Quantity }, // The maximum dose per day (maximum dose quantity to be administered in any one 24-h period) that can be administered as per the protocol referenced in the clinical trial authorisation "maxDosePerTreatmentPeriod" : { Ratio }, // The maximum dose per treatment period that can be administered as per the protocol referenced in the clinical trial authorisation "maxTreatmentPeriod" : { Duration }, // The maximum treatment period during which an Investigational Medicinal Product can be administered as per the protocol referenced in the clinical trial authorisation "targetSpecies" : [{ // A species for which this route applies "code" : { CodeableConcept }, // R! Coded expression for the species "withdrawalPeriod" : [{ // A species specific time during which consumption of animal product is not appropriate "tissue" : { CodeableConcept }, // R! Coded expression for the type of tissue for which the withdrawal period applues, e.g. meat, milk "value" : { Quantity }, // R! A value for the time "supportingInformation" : "<string>" // Extra information about the withdrawal period }] }] }] }
Turtle Template
@prefix fhir: <http://hl7.org/fhir/> . [ a fhir:AdministrableProductDefinition; fhir:nodeRole fhir:treeRoot; # if this is the parser root # from Resource: .id, .meta, .implicitRules, and .language # from DomainResource: .text, .contained, .extension, and .modifierExtension fhir:AdministrableProductDefinition.identifier [ Identifier ], ... ; # 0..* An identifier for the pharmaceutical medicinal product fhir:AdministrableProductDefinition.subject [ Reference(MedicinalProductDefinition) ], ... ; # 0..* The product that this is a pharmaceutical product of fhir:AdministrableProductDefinition.administrableDoseForm [ CodeableConcept ]; # 1..1 The administrable dose form, after necessary reconstitution fhir:AdministrableProductDefinition.unitOfPresentation [ CodeableConcept ]; # 0..1 Todo fhir:AdministrableProductDefinition.producedFrom [ Reference(ManufacturedItemDefinition) ], ... ; # 0..* The manufactured item(s) that this administrable product is produced from. Either a single item, or several that are mixed before administration (e.g. a power item and a solution item). Note that these are not raw ingredients fhir:AdministrableProductDefinition.ingredient [ Reference(Ingredient) ], ... ; # 0..* The ingredients of this administrable pharmaceutical product fhir:AdministrableProductDefinition.device [ Reference(DeviceDefinition) ], ... ; # 0..* Accompanying device fhir:AdministrableProductDefinition.property [ # 0..* Characteristics e.g. a products onset of action fhir:AdministrableProductDefinition.property.type [ CodeableConcept ]; # 1..1 A code expressing the type of characteristic # AdministrableProductDefinition.property.value[x] : 0..1 A value for the characteristic. One of these 5 fhir:AdministrableProductDefinition.property.valueCodeableConcept [ CodeableConcept ] fhir:AdministrableProductDefinition.property.valueQuantity [ Quantity ] fhir:AdministrableProductDefinition.property.valueDate [ date ] fhir:AdministrableProductDefinition.property.valueBoolean [ boolean ] fhir:AdministrableProductDefinition.property.valueAttachment [ Attachment ] fhir:AdministrableProductDefinition.property.status [ CodeableConcept ]; # 0..1 The status of characteristic e.g. assigned or pending ], ...; fhir:AdministrableProductDefinition.routeOfAdministration [ # 1..* The path by which the pharmaceutical product is taken into or makes contact with the body fhir:AdministrableProductDefinition.routeOfAdministration.code [ CodeableConcept ]; # 1..1 Coded expression for the route fhir:AdministrableProductDefinition.routeOfAdministration.firstDose [ Quantity ]; # 0..1 The first dose (dose quantity) administered in humans can be specified, for a product under investigation, using a numerical value and its unit of measurement fhir:AdministrableProductDefinition.routeOfAdministration.maxSingleDose [ Quantity ]; # 0..1 The maximum single dose that can be administered as per the protocol of a clinical trial can be specified using a numerical value and its unit of measurement fhir:AdministrableProductDefinition.routeOfAdministration.maxDosePerDay [ Quantity ]; # 0..1 The maximum dose per day (maximum dose quantity to be administered in any one 24-h period) that can be administered as per the protocol referenced in the clinical trial authorisation fhir:AdministrableProductDefinition.routeOfAdministration.maxDosePerTreatmentPeriod [ Ratio ]; # 0..1 The maximum dose per treatment period that can be administered as per the protocol referenced in the clinical trial authorisation fhir:AdministrableProductDefinition.routeOfAdministration.maxTreatmentPeriod [ Duration ]; # 0..1 The maximum treatment period during which an Investigational Medicinal Product can be administered as per the protocol referenced in the clinical trial authorisation fhir:AdministrableProductDefinition.routeOfAdministration.targetSpecies [ # 0..* A species for which this route applies fhir:AdministrableProductDefinition.routeOfAdministration.targetSpecies.code [ CodeableConcept ]; # 1..1 Coded expression for the species fhir:AdministrableProductDefinition.routeOfAdministration.targetSpecies.withdrawalPeriod [ # 0..* A species specific time during which consumption of animal product is not appropriate fhir:AdministrableProductDefinition.routeOfAdministration.targetSpecies.withdrawalPeriod.tissue [ CodeableConcept ]; # 1..1 Coded expression for the type of tissue for which the withdrawal period applues, e.g. meat, milk fhir:AdministrableProductDefinition.routeOfAdministration.targetSpecies.withdrawalPeriod.value [ Quantity ]; # 1..1 A value for the time fhir:AdministrableProductDefinition.routeOfAdministration.targetSpecies.withdrawalPeriod.supportingInformation [ string ]; # 0..1 Extra information about the withdrawal period ], ...; ], ...; ], ...; ]
Structure
Name | Flags | Card. | Type | Description & Constraints |
---|---|---|---|---|
AdministrableProductDefinition | ΣTU | DomainResource | A pharmaceutical product described in terms of its composition and dose form Elements defined in Ancestors: id, meta, implicitRules, language, text, contained, extension, modifierExtension | |
identifier | Σ | 0..* | Identifier | An identifier for the pharmaceutical medicinal product |
subject | Σ | 0..* | Reference(MedicinalProductDefinition) | The product that this is a pharmaceutical product of |
administrableDoseForm | Σ | 1..1 | CodeableConcept | The administrable dose form, after necessary reconstitution |
unitOfPresentation | Σ | 0..1 | CodeableConcept | Todo |
producedFrom | Σ | 0..* | Reference(ManufacturedItemDefinition) | The manufactured item(s) that this administrable product is produced from. Either a single item, or several that are mixed before administration (e.g. a power item and a solution item). Note that these are not raw ingredients |
ingredient | Σ | 0..* | Reference(Ingredient) | The ingredients of this administrable pharmaceutical product |
device | Σ | 0..* | Reference(DeviceDefinition) | Accompanying device |
property | Σ | 0..* | BackboneElement | Characteristics e.g. a products onset of action |
type | Σ | 1..1 | CodeableConcept | A code expressing the type of characteristic |
value[x] | Σ | 0..1 | A value for the characteristic | |
valueCodeableConcept | CodeableConcept | |||
valueQuantity | Quantity | |||
valueDate | date | |||
valueBoolean | boolean | |||
valueAttachment | Attachment | |||
status | Σ | 0..1 | CodeableConcept | The status of characteristic e.g. assigned or pending |
routeOfAdministration | Σ | 1..* | BackboneElement | The path by which the pharmaceutical product is taken into or makes contact with the body |
code | Σ | 1..1 | CodeableConcept | Coded expression for the route |
firstDose | Σ | 0..1 | Quantity | The first dose (dose quantity) administered in humans can be specified, for a product under investigation, using a numerical value and its unit of measurement |
maxSingleDose | Σ | 0..1 | Quantity | The maximum single dose that can be administered as per the protocol of a clinical trial can be specified using a numerical value and its unit of measurement |
maxDosePerDay | Σ | 0..1 | Quantity | The maximum dose per day (maximum dose quantity to be administered in any one 24-h period) that can be administered as per the protocol referenced in the clinical trial authorisation |
maxDosePerTreatmentPeriod | Σ | 0..1 | Ratio | The maximum dose per treatment period that can be administered as per the protocol referenced in the clinical trial authorisation |
maxTreatmentPeriod | Σ | 0..1 | Duration | The maximum treatment period during which an Investigational Medicinal Product can be administered as per the protocol referenced in the clinical trial authorisation |
targetSpecies | Σ | 0..* | BackboneElement | A species for which this route applies |
code | Σ | 1..1 | CodeableConcept | Coded expression for the species |
withdrawalPeriod | Σ | 0..* | BackboneElement | A species specific time during which consumption of animal product is not appropriate |
tissue | Σ | 1..1 | CodeableConcept | Coded expression for the type of tissue for which the withdrawal period applues, e.g. meat, milk |
value | Σ | 1..1 | Quantity | A value for the time |
supportingInformation | Σ | 0..1 | string | Extra information about the withdrawal period |
Documentation for this format |
XML Template
<AdministrableProductDefinition xmlns="http://hl7.org/fhir"> <!-- from Resource: id, meta, implicitRules, and language --> <!-- from DomainResource: text, contained, extension, and modifierExtension --> <identifier><!-- 0..* Identifier An identifier for the pharmaceutical medicinal product --></identifier> <subject><!-- 0..* Reference(MedicinalProductDefinition) The product that this is a pharmaceutical product of --></subject> <administrableDoseForm><!-- 1..1 CodeableConcept The administrable dose form, after necessary reconstitution --></administrableDoseForm> <unitOfPresentation><!-- 0..1 CodeableConcept Todo --></unitOfPresentation> <producedFrom><!-- 0..* Reference(ManufacturedItemDefinition) The manufactured item(s) that this administrable product is produced from. Either a single item, or several that are mixed before administration (e.g. a power item and a solution item). Note that these are not raw ingredients --></producedFrom> <ingredient><!-- 0..* Reference(Ingredient) The ingredients of this administrable pharmaceutical product --></ingredient> <device><!-- 0..* Reference(DeviceDefinition) Accompanying device --></device> <property> <!-- 0..* Characteristics e.g. a products onset of action --> <type><!-- 1..1 CodeableConcept A code expressing the type of characteristic --></type> <value[x]><!-- 0..1 CodeableConcept|Quantity|date|boolean|Attachment A value for the characteristic --></value[x]> <status><!-- 0..1 CodeableConcept The status of characteristic e.g. assigned or pending --></status> </property> <routeOfAdministration> <!-- 1..* The path by which the pharmaceutical product is taken into or makes contact with the body --> <code><!-- 1..1 CodeableConcept Coded expression for the route --></code> <firstDose><!-- 0..1 Quantity The first dose (dose quantity) administered in humans can be specified, for a product under investigation, using a numerical value and its unit of measurement --></firstDose> <maxSingleDose><!-- 0..1 Quantity The maximum single dose that can be administered as per the protocol of a clinical trial can be specified using a numerical value and its unit of measurement --></maxSingleDose> <maxDosePerDay><!-- 0..1 Quantity The maximum dose per day (maximum dose quantity to be administered in any one 24-h period) that can be administered as per the protocol referenced in the clinical trial authorisation --></maxDosePerDay> <maxDosePerTreatmentPeriod><!-- 0..1 Ratio The maximum dose per treatment period that can be administered as per the protocol referenced in the clinical trial authorisation --></maxDosePerTreatmentPeriod> <maxTreatmentPeriod><!-- 0..1 Duration The maximum treatment period during which an Investigational Medicinal Product can be administered as per the protocol referenced in the clinical trial authorisation --></maxTreatmentPeriod> <targetSpecies> <!-- 0..* A species for which this route applies --> <code><!-- 1..1 CodeableConcept Coded expression for the species --></code> <withdrawalPeriod> <!-- 0..* A species specific time during which consumption of animal product is not appropriate --> <tissue><!-- 1..1 CodeableConcept Coded expression for the type of tissue for which the withdrawal period applues, e.g. meat, milk --></tissue> <value><!-- 1..1 Quantity A value for the time --></value> <supportingInformation value="[string]"/><!-- 0..1 Extra information about the withdrawal period --> </withdrawalPeriod> </targetSpecies> </routeOfAdministration> </AdministrableProductDefinition>
JSON Template
{ "resourceType" : "AdministrableProductDefinition", // from Resource: id, meta, implicitRules, and language // from DomainResource: text, contained, extension, and modifierExtension "identifier" : [{ Identifier }], // An identifier for the pharmaceutical medicinal product "subject" : [{ Reference(MedicinalProductDefinition) }], // The product that this is a pharmaceutical product of "administrableDoseForm" : { CodeableConcept }, // R! The administrable dose form, after necessary reconstitution "unitOfPresentation" : { CodeableConcept }, // Todo "producedFrom" : [{ Reference(ManufacturedItemDefinition) }], // The manufactured item(s) that this administrable product is produced from. Either a single item, or several that are mixed before administration (e.g. a power item and a solution item). Note that these are not raw ingredients "ingredient" : [{ Reference(Ingredient) }], // The ingredients of this administrable pharmaceutical product "device" : [{ Reference(DeviceDefinition) }], // Accompanying device "property" : [{ // Characteristics e.g. a products onset of action "type" : { CodeableConcept }, // R! A code expressing the type of characteristic // value[x]: A value for the characteristic. One of these 5: "valueCodeableConcept" : { CodeableConcept }, "valueQuantity" : { Quantity }, "valueDate" : "<date>", "valueBoolean" : <boolean>, "valueAttachment" : { Attachment }, "status" : { CodeableConcept } // The status of characteristic e.g. assigned or pending }], "routeOfAdministration" : [{ // R! The path by which the pharmaceutical product is taken into or makes contact with the body "code" : { CodeableConcept }, // R! Coded expression for the route "firstDose" : { Quantity }, // The first dose (dose quantity) administered in humans can be specified, for a product under investigation, using a numerical value and its unit of measurement "maxSingleDose" : { Quantity }, // The maximum single dose that can be administered as per the protocol of a clinical trial can be specified using a numerical value and its unit of measurement "maxDosePerDay" : { Quantity }, // The maximum dose per day (maximum dose quantity to be administered in any one 24-h period) that can be administered as per the protocol referenced in the clinical trial authorisation "maxDosePerTreatmentPeriod" : { Ratio }, // The maximum dose per treatment period that can be administered as per the protocol referenced in the clinical trial authorisation "maxTreatmentPeriod" : { Duration }, // The maximum treatment period during which an Investigational Medicinal Product can be administered as per the protocol referenced in the clinical trial authorisation "targetSpecies" : [{ // A species for which this route applies "code" : { CodeableConcept }, // R! Coded expression for the species "withdrawalPeriod" : [{ // A species specific time during which consumption of animal product is not appropriate "tissue" : { CodeableConcept }, // R! Coded expression for the type of tissue for which the withdrawal period applues, e.g. meat, milk "value" : { Quantity }, // R! A value for the time "supportingInformation" : "<string>" // Extra information about the withdrawal period }] }] }] }
Turtle Template
@prefix fhir: <http://hl7.org/fhir/> . [ a fhir:AdministrableProductDefinition; fhir:nodeRole fhir:treeRoot; # if this is the parser root # from Resource: .id, .meta, .implicitRules, and .language # from DomainResource: .text, .contained, .extension, and .modifierExtension fhir:AdministrableProductDefinition.identifier [ Identifier ], ... ; # 0..* An identifier for the pharmaceutical medicinal product fhir:AdministrableProductDefinition.subject [ Reference(MedicinalProductDefinition) ], ... ; # 0..* The product that this is a pharmaceutical product of fhir:AdministrableProductDefinition.administrableDoseForm [ CodeableConcept ]; # 1..1 The administrable dose form, after necessary reconstitution fhir:AdministrableProductDefinition.unitOfPresentation [ CodeableConcept ]; # 0..1 Todo fhir:AdministrableProductDefinition.producedFrom [ Reference(ManufacturedItemDefinition) ], ... ; # 0..* The manufactured item(s) that this administrable product is produced from. Either a single item, or several that are mixed before administration (e.g. a power item and a solution item). Note that these are not raw ingredients fhir:AdministrableProductDefinition.ingredient [ Reference(Ingredient) ], ... ; # 0..* The ingredients of this administrable pharmaceutical product fhir:AdministrableProductDefinition.device [ Reference(DeviceDefinition) ], ... ; # 0..* Accompanying device fhir:AdministrableProductDefinition.property [ # 0..* Characteristics e.g. a products onset of action fhir:AdministrableProductDefinition.property.type [ CodeableConcept ]; # 1..1 A code expressing the type of characteristic # AdministrableProductDefinition.property.value[x] : 0..1 A value for the characteristic. One of these 5 fhir:AdministrableProductDefinition.property.valueCodeableConcept [ CodeableConcept ] fhir:AdministrableProductDefinition.property.valueQuantity [ Quantity ] fhir:AdministrableProductDefinition.property.valueDate [ date ] fhir:AdministrableProductDefinition.property.valueBoolean [ boolean ] fhir:AdministrableProductDefinition.property.valueAttachment [ Attachment ] fhir:AdministrableProductDefinition.property.status [ CodeableConcept ]; # 0..1 The status of characteristic e.g. assigned or pending ], ...; fhir:AdministrableProductDefinition.routeOfAdministration [ # 1..* The path by which the pharmaceutical product is taken into or makes contact with the body fhir:AdministrableProductDefinition.routeOfAdministration.code [ CodeableConcept ]; # 1..1 Coded expression for the route fhir:AdministrableProductDefinition.routeOfAdministration.firstDose [ Quantity ]; # 0..1 The first dose (dose quantity) administered in humans can be specified, for a product under investigation, using a numerical value and its unit of measurement fhir:AdministrableProductDefinition.routeOfAdministration.maxSingleDose [ Quantity ]; # 0..1 The maximum single dose that can be administered as per the protocol of a clinical trial can be specified using a numerical value and its unit of measurement fhir:AdministrableProductDefinition.routeOfAdministration.maxDosePerDay [ Quantity ]; # 0..1 The maximum dose per day (maximum dose quantity to be administered in any one 24-h period) that can be administered as per the protocol referenced in the clinical trial authorisation fhir:AdministrableProductDefinition.routeOfAdministration.maxDosePerTreatmentPeriod [ Ratio ]; # 0..1 The maximum dose per treatment period that can be administered as per the protocol referenced in the clinical trial authorisation fhir:AdministrableProductDefinition.routeOfAdministration.maxTreatmentPeriod [ Duration ]; # 0..1 The maximum treatment period during which an Investigational Medicinal Product can be administered as per the protocol referenced in the clinical trial authorisation fhir:AdministrableProductDefinition.routeOfAdministration.targetSpecies [ # 0..* A species for which this route applies fhir:AdministrableProductDefinition.routeOfAdministration.targetSpecies.code [ CodeableConcept ]; # 1..1 Coded expression for the species fhir:AdministrableProductDefinition.routeOfAdministration.targetSpecies.withdrawalPeriod [ # 0..* A species specific time during which consumption of animal product is not appropriate fhir:AdministrableProductDefinition.routeOfAdministration.targetSpecies.withdrawalPeriod.tissue [ CodeableConcept ]; # 1..1 Coded expression for the type of tissue for which the withdrawal period applues, e.g. meat, milk fhir:AdministrableProductDefinition.routeOfAdministration.targetSpecies.withdrawalPeriod.value [ Quantity ]; # 1..1 A value for the time fhir:AdministrableProductDefinition.routeOfAdministration.targetSpecies.withdrawalPeriod.supportingInformation [ string ]; # 0..1 Extra information about the withdrawal period ], ...; ], ...; ], ...; ]
See the Profiles & Extensions and the alternate definitions: Master Definition XML + JSON, XML Schema/Schematron + JSON Schema, ShEx (for Turtle) + see the extensions, the spreadsheet version & the dependency analysis a
Search parameters for this resource. The common parameters also apply. See Searching for more information about searching in REST, messaging, and services.
Name | Type | Description | Expression | In Common |
dose-form | token | The administrable dose form, after necessary reconstitution | AdministrableProductDefinition.administrableDoseForm | |
identifier | token | An identifier for the pharmaceutical medicinal product | AdministrableProductDefinition.identifier | |
route | token | Coded expression for the route | AdministrableProductDefinition.routeOfAdministration.code | |
subject | reference | The product that this is a pharmaceutical product of | AdministrableProductDefinition.subject (MedicinalProductDefinition) | |
target-species | token | Coded expression for the species | AdministrableProductDefinition.routeOfAdministration.targetSpecies.code |